GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Purchase Of Investment

Nanopharmaceutics (Nanopharmaceutics) Purchase Of Investment : $0.00 Mil (TTM As of Sep. 2018)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Purchase Of Investment?

Nanopharmaceutics's purchase of investment for the three months ended in Sep. 2018 was $0.00 Mil. It means Nanopharmaceutics spent $0.00 Mil on purchasing investments. Nanopharmaceutics's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2018 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jun. 2018 ), Nanopharmaceutics spent the same money on purchasing investments in Sep. 2018 ($0.00 Mil).


Nanopharmaceutics Purchase Of Investment Historical Data

The historical data trend for Nanopharmaceutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Purchase Of Investment Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Purchase Of Investment
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanopharmaceutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanopharmaceutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Nanopharmaceutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.